What is the price target for CFRX stock?
7 analysts have analysed CFRX and the average price target is 5.1 USD. This implies a price increase of 2100.17% is expected in the next year compared to the current price of 0.2318.
CONTRAFECT CORP (CFRX) Forecast, Price Target & Analyst Ratings
NASDAQ:CFRX • US2123264093
Current stock price
0.2318 USD
+0.01 (+2.84%)
At close:
0.171 USD
-0.06 (-26.23%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CONTRAFECT CORP (CFRX).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Mar 29, 2024
- Period
- Q3 / 2023
- EPS Estimate
- -$0.67
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
$5.10
Upside
+ 2,100.17%
From current price of $0.23 to mean target of $5.10, Based on 7 analyst forecasts
Low
$3.03
Median
$5.10
High
$7.35
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
7 Wall Street analysts provided a forecast for the next 12 months for CFRX. The average price target is 5.1 USD. This implies a price increase of 2100.17% is expected in the next year compared to the current price of 0.2318.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
CFRX was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CFRX.
In the previous month the buy percentage consensus was at a similar level.
CFRX was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-04-13 | Maxim Group | Upgrade | Hold -> Buy |
| 2022-07-14 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2022-07-14 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2022-07-14 | Maxim Group | Downgrade | Buy -> Hold |
| 2022-06-08 | WBB Securities | Upgrade | Buy -> Strong Buy |
| 2022-02-16 | SVB Leerink | Maintains | Outperform |
| 2022-02-02 | WBB Securities | Upgrade | Speculative Buy -> Buy |
| 2021-09-09 | SVB Leerink | Initiate | Outperform |
| 2021-03-31 | WBB Securities | Initiate | Speculative Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Mar 29, 2024
- Period
- Q3 / 2023
- EPS Estimate
- -$0.67
- Revenue Estimate
- Revenue Q2Q
- N/A
- EPS Q2Q
- 96.34%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
65.63%
Next Earnings Summary
CFRX is expected to report earnings on 3/29/2024. The consensus EPS estimate for the next earnings is -0.67 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | |||||||||
| EBITDA YoY % growth | -24.53M | -33.08M -34.86% | -26.37M 20.28% | -30.97M -17.44% | -27.7M 10.56% | -34.07M -23.00% | -47.12M -38.30% | -58.34M -23.81% | N/A | N/A | N/A | |
| EBIT YoY % growth | -25.07M | -33.53M -33.75% | -26.56M 20.79% | -31.12M -17.17% | -27.87M 10.44% | -34.24M -22.86% | -47.27M -38.05% | -58.49M -23.74% | N/A 45.42% | N/A 4.15% | N/A -11.33% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -10.70 | -8.60 19.63% | -3.00 65.12% | -3.50 -16.67% | -1.41 59.71% | -1.48 -4.96% | -30.58 -1,966.22% | -112.14 -266.71% | N/A 96.87% | N/A 56.40% | N/A 26.00% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q3 / 23 | Q4 / 23 | |
|---|---|---|
| EPS Q2Q % growth | -0.67 96.34% | -0.70 95.64% |
| Revenue Q2Q % growth | ||
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -7.242M 54.05% | -7.548M -12.32% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
25.78%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
CONTRAFECT CORP / CFRX Forecast FAQ
Can you provide the upcoming earnings date for CONTRAFECT CORP?
CONTRAFECT CORP (CFRX) will report earnings on 2024-03-29, after the market close.
Can you provide the consensus estimates for CONTRAFECT CORP next earnings?
The consensus EPS estimate for the next earnings of CONTRAFECT CORP (CFRX) is -0.67 USD and the consensus revenue estimate is 0 USD.
Can you provide the consensus rating for CONTRAFECT CORP stock?
The consensus rating for CONTRAFECT CORP (CFRX) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.